Hudson Bay Capital Management LP Biomarin Pharmaceutical Inc Transaction History

Hudson Bay Capital Management LP

  • $24.1 Billion
  • Q4 2024

A detailed history of Hudson Bay Capital Management LP transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 460,000 shares of BMRN stock, worth $31.4 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
460,000
Previous 441,200 4.26%
Holding current value
$31.4 Million
Previous $31 Million 2.5%
% of portfolio
0.13%
Previous 0.14%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$61.93 - $70.49 $1.16 Million - $1.33 Million
18,800 Added 4.26%
460,000 $30.2 Million
Q3 2024

Nov 13, 2024
BUY
$69.02 - $93.84 $13.6 Million - $18.4 Million
196,500 Added 80.3%
441,200 $31 Million
Q2 2024

Aug 14, 2024
BUY
$74.43 - $92.22 $10 Million - $12.4 Million
134,800 Added 122.66%
244,700 $20.1 Million
Q1 2024

May 15, 2024
BUY
$83.81 - $99.0 $2.96 Million - $3.49 Million
35,287 Added 47.29%
109,900 $9.6 Million
Q4 2023

Feb 14, 2024
SELL
$76.22 - $98.51 $4.29 Million - $5.55 Million
-56,297 Reduced 43.0%
74,613 $7.19 Million
Q3 2023

Nov 14, 2023
BUY
$85.07 - $94.48 $6.63 Million - $7.36 Million
77,910 Added 147.0%
130,910 $11.6 Million
Q2 2023

Aug 14, 2023
BUY
$86.68 - $100.3 $1.99 Million - $2.31 Million
23,000 Added 76.67%
53,000 $4.59 Million
Q1 2023

May 15, 2023
SELL
$87.74 - $117.27 $5.26 Million - $7.04 Million
-60,000 Reduced 66.67%
30,000 $2.92 Million
Q4 2022

Feb 14, 2023
SELL
$80.93 - $108.63 $1.21 Million - $1.63 Million
-15,000 Reduced 14.29%
90,000 $9.31 Million
Q3 2022

Nov 14, 2022
SELL
$82.16 - $96.94 $2.95 Million - $3.48 Million
-35,890 Reduced 25.47%
105,000 $8.9 Million
Q2 2022

Aug 12, 2022
BUY
$71.48 - $86.85 $6.68 Million - $8.11 Million
93,390 Added 196.61%
140,890 $11.7 Million
Q1 2022

May 16, 2022
BUY
$74.28 - $92.69 $1.3 Million - $1.62 Million
17,500 Added 58.33%
47,500 $3.66 Million
Q4 2021

Feb 14, 2022
SELL
$71.72 - $91.47 $5.02 Million - $6.4 Million
-70,000 Reduced 70.0%
30,000 $2.65 Million
Q3 2021

Nov 15, 2021
BUY
$74.77 - $85.47 $1.12 Million - $1.28 Million
15,000 Added 17.65%
100,000 $7.73 Million
Q2 2021

Aug 16, 2021
SELL
$75.51 - $84.79 $566,325 - $635,925
-7,500 Reduced 8.11%
85,000 $7.09 Million
Q1 2021

May 14, 2021
SELL
$74.73 - $90.69 $186,825 - $226,725
-2,500 Reduced 2.63%
92,500 $6.99 Million
Q4 2020

Feb 12, 2021
BUY
$72.61 - $90.2 $3.14 Million - $3.91 Million
43,300 Added 83.75%
95,000 $8.33 Million
Q3 2020

Nov 12, 2020
SELL
$71.87 - $131.03 $1.67 Million - $3.05 Million
-23,300 Reduced 31.07%
51,700 $3.93 Million
Q2 2020

Aug 12, 2020
SELL
$79.55 - $124.22 $795,500 - $1.24 Million
-10,000 Reduced 11.76%
75,000 $9.25 Million
Q1 2020

May 14, 2020
SELL
$71.37 - $96.85 $3.57 Million - $4.84 Million
-50,000 Reduced 37.04%
85,000 $7.18 Million
Q4 2019

Feb 12, 2020
SELL
$64.27 - $86.37 $1.78 Million - $2.39 Million
-27,700 Reduced 17.03%
135,000 $11.4 Million
Q3 2019

Nov 13, 2019
BUY
$67.4 - $85.11 $4.23 Million - $5.34 Million
62,700 Added 62.7%
162,700 $11 Million
Q1 2019

May 15, 2019
SELL
$84.2 - $98.62 $842,000 - $986,200
-10,000 Reduced 9.09%
100,000 $8.88 Million
Q4 2018

Feb 13, 2019
BUY
$80.14 - $106.07 $801,400 - $1.06 Million
10,000 Added 10.0%
110,000 $9.37 Million
Q2 2018

Aug 13, 2018
SELL
$76.01 - $99.03 $3.04 Million - $3.96 Million
-40,000 Reduced 28.57%
100,000 $9.42 Million
Q1 2018

May 14, 2018
BUY
$77.67 - $92.63 $2.33 Million - $2.78 Million
30,000 Added 27.27%
140,000 $11.4 Million
Q4 2017

Feb 12, 2018
SELL
$80.76 - $95.13 $6.1 Million - $7.18 Million
-75,500 Reduced 40.7%
110,000 $9.81 Million
Q3 2017

Nov 13, 2017
BUY
$80.6 - $94.95 $15 Million - $17.6 Million
185,500
185,500 $17.3 Million

Others Institutions Holding BMRN

# of Institutions
626
Shares Held
183M
Call Options Held
2M
Put Options Held
1.67M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.7B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Hudson Bay Capital Management LP Portfolio

Follow Hudson Bay Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email